BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 910440 O=c1cc(C2CCNCC2)n2nc3ccccc3c2[nH]1 InChI=1S/C15H16N4O/c20-14-9-13(10-5-7-16-8-6-10)19-15(17-14)11-3-1-2-4-12(11)18-19/h1-4,9-10,16H,5-8H2,(H,17,20) HPNRKQHUJWHTEL-UHFFFAOYSA-N 290260 4-(Piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 1::US10668071, Example 1 Plasminogen [101-181] Human 51.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290260&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528546 381610591 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910441 FC(F)(F)c1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)10-1-2-12-11(7-10)15-21-14(24)8-13(23(15)22-12)9-3-5-20-6-4-9/h1-2,7-9,20H,3-6H2,(H,21,24) GFNFRFNJUILJLD-UHFFFAOYSA-N 290261 4-(Piperidin-4-yl)-9-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 2::US10668071, Example 2 Plasminogen [101-181] Human 30.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290261&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528547 381610592 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910442 Clc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) JCSOBBNZRLXNCX-UHFFFAOYSA-N 290262 10-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 3::US10098883, Example 66::US10668071, Example 66 Plasminogen [101-181] Human 28.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290262&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528548 381610593 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910443 Fc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15FN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) RHUQDSVUQAZXCT-UHFFFAOYSA-N 290263 10-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 4::US10668071, Example 4 Plasminogen [101-181] Human 28.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290263&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528549 381610594 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910444 Clc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) PRICXLGTYNSXDL-UHFFFAOYSA-N 290264 9-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 5::US10668071, Example 5 Plasminogen [101-181] Human 37.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290264&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528550 381610595 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910445 Clc1cc(Cl)c2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H14Cl2N4O/c16-9-5-10-14(11(17)6-9)20-21-12(7-13(22)19-15(10)21)8-1-3-18-4-2-8/h5-8,18H,1-4H2,(H,19,22) SSHONGPABJSMOF-UHFFFAOYSA-N 290265 7,9-Dichloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 6::US10668071, Example 6 Plasminogen [101-181] Human 94.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290265&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528551 381610596 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910446 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15FN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) JXXOFJAXELERBQ-UHFFFAOYSA-N 290266 9-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 7::US10668071, Example 7 Plasminogen [101-181] Human 95.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290266&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528552 381610597 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910447 COc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H18N4O2/c1-22-13-4-2-3-11-15(13)16-18-14(21)9-12(20(16)19-11)10-5-7-17-8-6-10/h2-4,9-10,17H,5-8H2,1H3,(H,18,21) WQLRCDTYQYYYQO-UHFFFAOYSA-N 290267 10-Methoxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 8::US10668071, Example 8 Plasminogen [101-181] Human 46.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290267&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528553 381610598 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910448 O=c1cc(C2CCNCC2)n2nc3cccnc3c2[nH]1 InChI=1S/C14H15N5O/c20-12-8-11(9-3-6-15-7-4-9)19-14(17-12)13-10(18-19)2-1-5-16-13/h1-2,5,8-9,15H,3-4,6-7H2,(H,17,20) HGLONKBLUQHOKG-UHFFFAOYSA-N 290268 7-(Piperidin-4-yl)pyrido[3′,2′:3,4]pyrazolo[1,5-a]pyrimidin-9(10H)-one hydrochloride::US10098883, Example 9::US10668071, Example 9 Plasminogen [101-181] Human 36.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290268&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528554 381610599 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910449 Brc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) BKPYMMXDHTZIRB-UHFFFAOYSA-N 290269 10-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 10::US10098883, Example 60::US10668071, Example 60 Plasminogen [101-181] Human 34.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290269&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528555 381610600 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910450 FC(F)(F)c1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)10-1-2-11-12(7-10)22-23-13(8-14(24)21-15(11)23)9-3-5-20-6-4-9/h1-2,7-9,20H,3-6H2,(H,21,24) FSHIRUYVKZDVTM-UHFFFAOYSA-N 290270 4-(Piperidin-4-yl)-8-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 11::US10668071, Example 11 Plasminogen [101-181] Human 26.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290270&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528556 381610601 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910451 FC(F)(F)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)10-2-1-3-11-14(10)15-21-13(24)8-12(23(15)22-11)9-4-6-20-7-5-9/h1-3,8-9,20H,4-7H2,(H,21,24) MWWYRQSZLGEKSJ-UHFFFAOYSA-N 290271 4-(Piperidin-4-yl)-10-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 12::US10668071, Example 12 Plasminogen [101-181] Human 32.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290271&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528557 381610602 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910452 CC(C)(C)c1ccc2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1 InChI=1S/C18H23N5O/c1-18(2,3)14-5-4-12-16(20-14)22-23-13(10-15(24)21-17(12)23)11-6-8-19-9-7-11/h4-5,10-11,19H,6-9H2,1-3H3,(H,21,24) ZLFKSRIVXCBDMD-UHFFFAOYSA-N 290272 8-tert-Butyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 13::US10668071, Example 13 Plasminogen [101-181] Human 31.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290272&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528558 381610603 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910453 Cc1cc(nc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1)C(F)(F)F InChI=1S/C16H16F3N5O/c1-8-6-11(16(17,18)19)21-14-13(8)15-22-12(25)7-10(24(15)23-14)9-2-4-20-5-3-9/h6-7,9,20H,2-5H2,1H3,(H,22,25) UTRWAAYVXMAEAV-UHFFFAOYSA-N 444987 10-Methyl-4-(piperidin-4-yl)-8-(trifluoromethyl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one Hydrochloride::US10668071, Example 14 Plasminogen [101-181] Human 50.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=444987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=444987&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 155802665 440707224 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910454 Cc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C16H18N4O/c1-10-2-3-13-12(8-10)16-18-15(21)9-14(20(16)19-13)11-4-6-17-7-5-11/h2-3,8-9,11,17H,4-7H2,1H3,(H,18,21) VPDJLDIIMHAMJP-UHFFFAOYSA-N 290274 9-Methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 15::US10668071, Example 15 Plasminogen [101-181] Human 48.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290274&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528560 381610605 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910455 Nc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H17N5O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6,16H2,(H,18,21) SLCFKUHMCXQXHP-UHFFFAOYSA-N 290275 8-Amino-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 16::US10668071, Example 16 Plasminogen [101-181] Human 34.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290275&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528561 381610606 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910456 Cc1nnc2nn3c(cc(=O)[nH]c3c2c1C)C1CCNCC1 InChI=1S/C15H18N6O/c1-8-9(2)18-19-14-13(8)15-17-12(22)7-11(21(15)20-14)10-3-5-16-6-4-10/h7,10,16H,3-6H2,1-2H3,(H,17,22) YYFWEPCJQMLKDX-UHFFFAOYSA-N 290276 3,4-Dimethyl-8-(piperidin-4-yl)pyrimido[1′,2′:1,5]pyrazolo[3,4-c]pyridazin-6(5H)-one hydrochloride::US10098883, Example 17::US10668071, Example 17 Plasminogen [101-181] Human 22.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290276&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528562 381610607 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910457 Fc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15FN4O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) DZMASZZVHCWZFC-UHFFFAOYSA-N 290277 8-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 18::US10668071, Example 18 Plasminogen [101-181] Human 38.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290277&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528563 381610608 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910458 Brc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) GWVROZAXAXKXKI-UHFFFAOYSA-N 290278 9-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 19::US10668071, Example 19 Plasminogen [101-181] Human 26.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290278&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528564 381610609 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910459 Ic1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15IN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) RPORPQKHOHAYAZ-UHFFFAOYSA-N 290279 10-Iodo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 20::US10668071, Example 20 Plasminogen [101-181] Human 22.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290279&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528565 381610610 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910460 Brc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) RJMLIAUBTZAZAW-UHFFFAOYSA-N 290280 8-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 21::US10668071, Example 21 Plasminogen [101-181] Human 30.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290280&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528566 381610611 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910461 Clc1cccc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-11-3-1-2-10-14(11)19-20-12(8-13(21)18-15(10)20)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) OGFDFQQGEVNHMI-UHFFFAOYSA-N 290281 7-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 22::US10668071, Example 22 Plasminogen [101-181] Human 26.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290281&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528567 381610612 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910462 Fc1cc(F)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H14F2N4O/c16-9-5-10(17)14-11(6-9)20-21-12(7-13(22)19-15(14)21)8-1-3-18-4-2-8/h5-8,18H,1-4H2,(H,19,22) HMVPUPFKGUWTAG-UHFFFAOYSA-N 290282 8,10-Difluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 23::US10668071, Example 23 Plasminogen [101-181] Human 28.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290282&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528568 381610613 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910463 Cc1ccc2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1 InChI=1S/C15H17N5O/c1-9-2-3-11-14(17-9)19-20-12(8-13(21)18-15(11)20)10-4-6-16-7-5-10/h2-3,8,10,16H,4-7H2,1H3,(H,18,21) SNMCZBPEZREHJL-UHFFFAOYSA-N 290283 8-Methyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 24::US10668071, Example 24 Plasminogen [101-181] Human 34.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290283&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528569 381610614 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910464 Fc1cnc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C14H14FN5O/c15-9-5-10-13(17-7-9)14-18-12(21)6-11(20(14)19-10)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) ABUQBVRNGFQAQF-UHFFFAOYSA-N 290284 3-Fluoro-7-(piperidin-4-yl)pyrido[3′,2′:3,4]pyrazolo[1,5-a]pyrimidin-9(10H)-one hydrochloride::US10098883, Example 25::US10668071, Example 25 Plasminogen [101-181] Human 21.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290284&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528570 381610615 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910465 CCOc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C17H20N4O2/c1-2-23-14-5-3-4-12-16(14)17-19-15(22)10-13(21(17)20-12)11-6-8-18-9-7-11/h3-5,10-11,18H,2,6-9H2,1H3,(H,19,22) IYXBEHMDMMXMTH-UHFFFAOYSA-N 290285 10-Ethoxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 26::US10668071, Example 26 Plasminogen [101-181] Human 29.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290285&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528571 381610616 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910466 Brc1cncc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C14H14BrN5O/c15-10-7-17-6-9-13(10)19-20-11(5-12(21)18-14(9)20)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) DMNCQTDNJQKQQV-UHFFFAOYSA-N 290286 7-Bromo-4-(piperidin-4-yl)pyrido[4′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 27::US10668071, Example 27 Plasminogen [101-181] Human 13.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290286&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528572 381610617 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910467 Fc1cccc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15FN4O/c16-11-3-1-2-10-14(11)19-20-12(8-13(21)18-15(10)20)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) WIABCIDGQJRJRH-UHFFFAOYSA-N 290287 7-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 28::US10668071, Example 28 Plasminogen [101-181] Human 33.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290287&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528573 381610618 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910468 O=c1cc(C2CCNCC2)n2nc3cnccc3c2[nH]1 InChI=1S/C14H15N5O/c20-13-7-12(9-1-4-15-5-2-9)19-14(17-13)10-3-6-16-8-11(10)18-19/h3,6-9,15H,1-2,4-5H2,(H,17,20) KMMAWAMCHYHUQX-UHFFFAOYSA-N 290288 4-(Piperidin-4-yl)pyrido[3′,4′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 29::US10668071, Example 29 Plasminogen [101-181] Human 28.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290288&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528574 381610619 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910469 FC(F)(F)c1cccc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)11-3-1-2-10-14(11)22-23-12(8-13(24)21-15(10)23)9-4-6-20-7-5-9/h1-3,8-9,20H,4-7H2,(H,21,24) ZTPKBFCZDGGBAL-UHFFFAOYSA-N 290289 4-(Piperidin-4-yl)-7-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 30::US10668071, Example 30 Plasminogen [101-181] Human 46.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290289&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528575 381610620 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910470 [O-][N+](=O)c1cc(cc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1)C(F)(F)F InChI=1S/C16H14F3N5O3/c17-16(18,19)9-5-10-14(12(6-9)24(26)27)15-21-13(25)7-11(23(15)22-10)8-1-3-20-4-2-8/h5-8,20H,1-4H2,(H,21,25) CHDYOAPLSOGCCS-UHFFFAOYSA-N 290290 10-Nitro-4-(piperidin-4-yl)-8-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 31::US10668071, Example 31 Plasminogen [101-181] Human 97.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290290&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528576 381610621 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910471 Cc1cc(C)c2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1 InChI=1S/C16H19N5O/c1-9-7-10(2)18-15-14(9)16-19-13(22)8-12(21(16)20-15)11-3-5-17-6-4-11/h7-8,11,17H,3-6H2,1-2H3,(H,19,22) RHESWYNPQQFDFT-UHFFFAOYSA-N 290291 8,10-Dimethyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 32::US10668071, Example 32 Plasminogen [101-181] Human 210 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290291&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528577 381610622 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910472 O=c1cc(C2CCNCC2)n2nc3cccc(C#N)c3c2[nH]1 InChI=1S/C16H15N5O/c17-9-11-2-1-3-12-15(11)16-19-14(22)8-13(21(16)20-12)10-4-6-18-7-5-10/h1-3,8,10,18H,4-7H2,(H,19,22) VARWJCCPAVWDOP-UHFFFAOYSA-N 290292 2-Oxo-4-(piperidin-4-yl)-1,2-dihydropyrimido[1,2-b]indazole-10-carbonitrile trifluoroacetate::US10098883, Example 33::US10098883, Example 53::US10668071, Example 53 Plasminogen [101-181] Human 21.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290292&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528578 381610623 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910473 Cc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H18N4O/c1-10-3-2-4-12-15(10)16-18-14(21)9-13(20(16)19-12)11-5-7-17-8-6-11/h2-4,9,11,17H,5-8H2,1H3,(H,18,21) AUYZSLJCFGTZMG-UHFFFAOYSA-N 290293 10-Methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 36::US10668071, Example 36 Plasminogen [101-181] Human 18.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290293&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528579 381610624 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910474 FC(F)(F)Oc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H15F3N4O2/c17-16(18,19)25-12-3-1-2-10-14(12)15-21-13(24)8-11(23(15)22-10)9-4-6-20-7-5-9/h1-3,8-9,20H,4-7H2,(H,21,24) IWPOEKPSVCPFMS-UHFFFAOYSA-N 290294 4-(Piperidin-4-yl)-10-(trifluoromethoxy)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 37::US10668071, Example 37 Plasminogen [101-181] Human 44.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290294&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528580 381610625 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910475 O=c1cc(C2CCNCC2)n2nc3nccnc3c2[nH]1 InChI=1S/C13H14N6O/c20-10-7-9(8-1-3-14-4-2-8)19-13(17-10)11-12(18-19)16-6-5-15-11/h5-8,14H,1-4H2,(H,17,20) HJPUROSFQNIPTE-UHFFFAOYSA-N 290295 7-(Piperidin-4-yl)pyrazino[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-9(10H)-one hydrochloride::US10098883, Example 38::US10668071, Example 38 Plasminogen [101-181] Human 60.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290295&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528581 381610626 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910476 Clc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) IYEYYIYNTPIERT-UHFFFAOYSA-N 290296 8-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 39::US10668071, Example 39 Plasminogen [101-181] Human 24.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290296&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528582 381610627 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910477 CN(C)c1ccnc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H20N6O/c1-21(2)11-5-8-18-15-14(11)16-19-13(23)9-12(22(16)20-15)10-3-6-17-7-4-10/h5,8-10,17H,3-4,6-7H2,1-2H3,(H,19,23) ZDWJNBGZTOXAJW-UHFFFAOYSA-N 290297 10-(Dimethylamino)-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 40::US10668071, Example 40 Plasminogen [101-181] Human 38.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290297&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528583 381610628 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910478 FC(F)(F)c1cc(Cl)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H14ClF3N4O/c17-10-5-9(16(18,19)20)6-11-14(10)15-22-13(25)7-12(24(15)23-11)8-1-3-21-4-2-8/h5-8,21H,1-4H2,(H,22,25) UZEYIKKYKOKFPO-UHFFFAOYSA-N 290298 10-Chloro-4-(piperidin-4-yl)-8-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 41::US10668071, Example 41 Plasminogen [101-181] Human 23.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290298&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528584 381610629 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910479 Fc1ccc(cc1)-c1cc(c2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1)C(F)(F)F InChI=1S/C21H17F4N5O/c22-13-3-1-11(2-4-13)15-9-14(21(23,24)25)18-19(27-15)29-30-16(10-17(31)28-20(18)30)12-5-7-26-8-6-12/h1-4,9-10,12,26H,5-8H2,(H,28,31) BQGXJQOCDDVKKK-UHFFFAOYSA-N 290299 8-(4-Fluorophenyl)-4-(piperidin-4-yl)-10-(trifluoromethyl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 42::US10668071, Example 42 Plasminogen [101-181] Human 110 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290299&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528585 381610630 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910480 Brc1cncc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C14H14BrN5O/c15-9-6-17-7-10-13(9)14-18-12(21)5-11(20(14)19-10)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) ZHKBNDBMMKLYTQ-UHFFFAOYSA-N 290300 10-Bromo-4-(piperidin-4-yl)pyrido[3′,4′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 43::US10668071, Example 43 Plasminogen [101-181] Human 100.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290300&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528586 381610631 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910481 O=c1cc(C2CCNCC2)n2nc3nc(ccc3c2[nH]1)-c1ccccc1 InChI=1S/C20H19N5O/c26-18-12-17(14-8-10-21-11-9-14)25-20(23-18)15-6-7-16(22-19(15)24-25)13-4-2-1-3-5-13/h1-7,12,14,21H,8-11H2,(H,23,26) ZLQHQTMJADACHZ-UHFFFAOYSA-N 290301 8-Phenyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 44::US10668071, Example 44 Plasminogen [101-181] Human 48.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290301&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528587 381610632 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910482 O=c1cc(C2CCNCC2)n2nc3ncc(cc3c2[nH]1)-c1ccccc1 InChI=1S/C20H19N5O/c26-18-11-17(14-6-8-21-9-7-14)25-20(23-18)16-10-15(12-22-19(16)24-25)13-4-2-1-3-5-13/h1-5,10-12,14,21H,6-9H2,(H,23,26) ZPVLVOJNQVFMTP-UHFFFAOYSA-N 290302 9-Phenyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 45::US10668071, Example 45 Plasminogen [101-181] Human 37.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290302&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528588 381610633 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910483 O=c1cc(C2CCNCC2)n2nc3nccc(-c4ccccc4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-17-12-16(14-6-9-21-10-7-14)25-20(23-17)18-15(8-11-22-19(18)24-25)13-4-2-1-3-5-13/h1-5,8,11-12,14,21H,6-7,9-10H2,(H,23,26) OJHXCSOJNDGQLJ-UHFFFAOYSA-N 290303 10-Phenyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 46::US10668071, Example 46 Plasminogen [101-181] Human 17.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290303&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528589 381610634 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910484 Cc1ccnc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H17N5O/c1-9-2-7-17-14-13(9)15-18-12(21)8-11(20(15)19-14)10-3-5-16-6-4-10/h2,7-8,10,16H,3-6H2,1H3,(H,18,21) DZMUXQUVMLDOSJ-UHFFFAOYSA-N 290304 10-methyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 47::US10668071, Example 47 Plasminogen [101-181] Human 24.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290304&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528590 381610635 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910485 Ic1cnc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C14H14IN5O/c15-9-5-10-13(17-7-9)19-20-11(6-12(21)18-14(10)20)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) YFZHYFBUHODJLH-UHFFFAOYSA-N 445019 9-Iodo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one Hydrochloride::US10668071, Example 48 Plasminogen [101-181] Human 36.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=445019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=445019&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 155802669 440707254 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910486 O=c1cc(C2CCNCC2)n2nc3ccncc3c2[nH]1 InChI=1S/C14H15N5O/c20-13-7-12(9-1-4-15-5-2-9)19-14(17-13)10-8-16-6-3-11(10)18-19/h3,6-9,15H,1-2,4-5H2,(H,17,20) DPXLRNOLDIASIW-UHFFFAOYSA-N 290306 4-(Piperidin-4-yl)pyrido[4′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one::US10098883, Example 49::US10668071, Example 49 Plasminogen [101-181] Human 36.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290306&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 136962641 381610637 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910487 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(Br)cccc3nn12 290307 (−)-trans-10-Bromo-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 50::US10668071, Example 50 Plasminogen [101-181] Human 14.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290307&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528592 381610638 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910488 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(ccnc3nn12)-c1ccccc1 290308 (−)-trans-4-(2-Methylpiperidin-4-yl)-10-phenylpyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10098883, Example 51::US10668071, Example 51 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290308&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528593 381610639 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910489 CCOc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNC(C)C1 290309 (−)-trans-10-Ethoxy-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 52::US10668071, Example 52 Plasminogen [101-181] Human 13.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290309&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528594 381610640 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910490 O=c1cc(C2CCNCC2)n2nc3cccc(C#N)c3c2[nH]1 InChI=1S/C16H15N5O/c17-9-11-2-1-3-12-15(11)16-19-14(22)8-13(21(16)20-12)10-4-6-18-7-5-10/h1-3,8,10,18H,4-7H2,(H,19,22) VARWJCCPAVWDOP-UHFFFAOYSA-N 290292 2-Oxo-4-(piperidin-4-yl)-1,2-dihydropyrimido[1,2-b]indazole-10-carbonitrile trifluoroacetate::US10098883, Example 33::US10098883, Example 53::US10668071, Example 53 Plasminogen [101-181] Human 10.00 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290292&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528578 381610623 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910491 COc1ccc(cc1)-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H22N4O2/c1-28-16-7-5-14(6-8-16)17-3-2-4-18-21(17)22-24-20(27)13-19(26(22)25-18)15-9-11-23-12-10-15/h2-8,13,15,23H,9-12H2,1H3,(H,24,27) VDHQRCWDKVFJBT-UHFFFAOYSA-N 290311 10-(4-Methoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 54::US10668071, Example 54 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290311&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528595 381610641 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910492 FC(F)(F)c1ccc(cc1)-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H19F3N4O/c23-22(24,25)15-6-4-13(5-7-15)16-2-1-3-17-20(16)21-27-19(30)12-18(29(21)28-17)14-8-10-26-11-9-14/h1-7,12,14,26H,8-11H2,(H,27,30) NZFZUOWLGZSFLE-UHFFFAOYSA-N 290312 4-(Piperidin-4-yl)-10-[4-(trifluoromethyl)phenyl]pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 55::US10668071, Example 55 Plasminogen [101-181] Human 14.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290312&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528596 381610642 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910493 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccccc4)c3c2[nH]1 InChI=1S/C21H20N4O/c26-19-13-18(15-9-11-22-12-10-15)25-21(23-19)20-16(7-4-8-17(20)24-25)14-5-2-1-3-6-14/h1-8,13,15,22H,9-12H2,(H,23,26) QUGXDBXLYYVTOS-UHFFFAOYSA-N 290313 10-Phenyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 56::US10668071, Example 56 Plasminogen [101-181] Human 14.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290313&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528597 381610643 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910494 Fc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H19FN4O/c22-16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-24-19(27)12-18(26(21)25-17)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) VPTAHBAWJZYJEI-UHFFFAOYSA-N 290314 10-(2-Fluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 57::US10098883, Example 95::US10668071, Example 95 Plasminogen [101-181] Human 13.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290314&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528598 381610644 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910495 O=c1cc(C2CCNCC2)n2nc3cccc(-c4cccnc4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-18-11-17(13-6-9-21-10-7-13)25-20(23-18)19-15(4-1-5-16(19)24-25)14-3-2-8-22-12-14/h1-5,8,11-13,21H,6-7,9-10H2,(H,23,26) FRVSRKWGOJYWGY-UHFFFAOYSA-N 290315 4-(Piperidin-4-yl)-10-(pyridin-3-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 58::US10668071, Example 58 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290315&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528599 381610645 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910496 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccncc4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-18-12-17(14-6-10-22-11-7-14)25-20(23-18)19-15(2-1-3-16(19)24-25)13-4-8-21-9-5-13/h1-5,8-9,12,14,22H,6-7,10-11H2,(H,23,26) RUSMVUILCGMPLP-UHFFFAOYSA-N 290316 4-(Piperidin-4-yl)-10-(pyridin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 59::US10668071, Example 59 Plasminogen [101-181] Human 16.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290316&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528600 381610646 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910497 Brc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) BKPYMMXDHTZIRB-UHFFFAOYSA-N 290269 10-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 10::US10098883, Example 60::US10668071, Example 60 Plasminogen [101-181] Human 14.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290269&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528555 381610600 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910498 O=c1cc(C2CCNCC2)n2nc3cccc(C4CC4)c3c2[nH]1 InChI=1S/C18H20N4O/c23-16-10-15(12-6-8-19-9-7-12)22-18(20-16)17-13(11-4-5-11)2-1-3-14(17)21-22/h1-3,10-12,19H,4-9H2,(H,20,23) YIMXTWHVFLKBCH-UHFFFAOYSA-N 290318 10-Cyclopropyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 61::US10668071, Example 61 Plasminogen [101-181] Human 24.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290318&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528601 381610647 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910499 CC(C)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C18H22N4O/c1-11(2)13-4-3-5-14-17(13)18-20-16(23)10-15(22(18)21-14)12-6-8-19-9-7-12/h3-5,10-12,19H,6-9H2,1-2H3,(H,20,23) OWUPQPJVQYHCSV-UHFFFAOYSA-N 290319 10-Isopropyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 62::US10668071, Example 62 Plasminogen [101-181] Human 18.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290319&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528602 381610648 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910500 O=c1cc(C2CCNCC2)n2nc3cccc(C4CCCC4)c3c2[nH]1 InChI=1S/C20H24N4O/c25-18-12-17(14-8-10-21-11-9-14)24-20(22-18)19-15(13-4-1-2-5-13)6-3-7-16(19)23-24/h3,6-7,12-14,21H,1-2,4-5,8-11H2,(H,22,25) YWHIHFGWPXDHQL-UHFFFAOYSA-N 290320 10-Cyclopentyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 63::US10668071, Example 63 Plasminogen [101-181] Human 13.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290320&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528603 381610649 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910501 Clc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H19ClN4O/c22-16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-24-19(27)12-18(26(21)25-17)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) GEFBYTYDFYHTGN-UHFFFAOYSA-N 290321 10-(2-Chlorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 64::US10668071, Example 64 Plasminogen [101-181] Human 19.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290321&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528604 381610650 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910502 COc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H22N4O2/c1-28-19-8-3-2-5-15(19)16-6-4-7-17-21(16)22-24-20(27)13-18(26(22)25-17)14-9-11-23-12-10-14/h2-8,13-14,23H,9-12H2,1H3,(H,24,27) HAXFUUKOQPVIRI-UHFFFAOYSA-N 290322 10-(2-Methoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 65::US10668071, Example 65 Plasminogen [101-181] Human 25.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290322&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528605 381610651 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910503 Clc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) JCSOBBNZRLXNCX-UHFFFAOYSA-N 290262 10-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 3::US10098883, Example 66::US10668071, Example 66 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290262&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528548 381610593 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910504 FC(F)(F)c1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H19F3N4O/c23-22(24,25)16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-27-19(30)12-18(29(21)28-17)13-8-10-26-11-9-13/h1-7,12-13,26H,8-11H2,(H,27,30) HRTZQFUZXIJCKY-UHFFFAOYSA-N 290324 4-(Piperidin-4-yl)-10-[2-(trifluoromethyl)phenyl]pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 67::US10668071, Example 67 Plasminogen [101-181] Human 13.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290324&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528606 381610652 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910505 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(Cl)cccc3nn12 290325 (−)-trans-10-Chloro-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 68::US10668071, Example 101 Plasminogen [101-181] Human 25.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290325&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528607 381610653 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910506 Cc1ccc2nn3c(cc(=O)[nH]c3c2c1Cl)C1CCNCC1 InChI=1S/C16H17ClN4O/c1-9-2-3-11-14(15(9)17)16-19-13(22)8-12(21(16)20-11)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) NIQBDMIDYSLUMX-UHFFFAOYSA-N 290326 10-Chloro-9-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 69::US10668071, Example 69 Plasminogen [101-181] Human 20.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290326&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528608 381610654 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910507 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1Br)C1CCNCC1 InChI=1S/C15H14BrFN4O/c16-14-9(17)1-2-10-13(14)15-19-12(22)7-11(21(15)20-10)8-3-5-18-6-4-8/h1-2,7-8,18H,3-6H2,(H,19,22) OCFHKLIUAGLQDX-UHFFFAOYSA-N 290327 10-Bromo-9-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 70::US10668071, Example 70 Plasminogen [101-181] Human 35.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290327&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528609 381610655 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910508 Fc1ccc(Br)c2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H14BrFN4O/c16-9-1-2-10(17)14-13(9)15-19-12(22)7-11(21(15)20-14)8-3-5-18-6-4-8/h1-2,7-8,18H,3-6H2,(H,19,22) DFOWSDNPCSTZTD-UHFFFAOYSA-N 290328 10-Bromo-7-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 71::US10668071, Example 71 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290328&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528610 381610656 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910509 CCC(C)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 290329 10-sec-Butyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 72::US10668071, Example 72 Plasminogen [101-181] Human 14.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290329&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528611 381610657 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910510 CC(C)Cc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H24N4O/c1-12(2)10-14-4-3-5-15-18(14)19-21-17(24)11-16(23(19)22-15)13-6-8-20-9-7-13/h3-5,11-13,20H,6-10H2,1-2H3,(H,21,24) KFWANCJBWKMZJS-UHFFFAOYSA-N 290330 10-Isobutyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 73::US10668071, Example 73 Plasminogen [101-181] Human 23.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290330&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528612 381610658 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910511 Cc1ccc2nn3c(cc(=O)[nH]c3c2c1Br)C1CCNCC1 InChI=1S/C16H17BrN4O/c1-9-2-3-11-14(15(9)17)16-19-13(22)8-12(21(16)20-11)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) QYSSTLHEYBWPLJ-UHFFFAOYSA-N 290331 10-Bromo-9-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 74::US10668071, Example 74 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290331&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528613 381610659 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910512 Cc1ccc(Br)c2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17BrN4O/c1-9-2-3-11(17)14-15(9)20-21-12(8-13(22)19-16(14)21)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) HNFQVGJYINLRAE-UHFFFAOYSA-N 290332 10-Bromo-7-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 75::US10668071, Example 75 Plasminogen [101-181] Human 16.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290332&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528614 381610660 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910513 CC(C)Oc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C18H22N4O2/c1-11(2)24-15-5-3-4-13-17(15)18-20-16(23)10-14(22(18)21-13)12-6-8-19-9-7-12/h3-5,10-12,19H,6-9H2,1-2H3,(H,20,23) JMPSZUYOCQBHEK-UHFFFAOYSA-N 290333 10-Isopropoxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 76::US10668071, Example 76 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290333&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528615 381610661 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910514 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1-c1ccccc1)C1CCNCC1 InChI=1S/C21H19FN4O/c22-15-6-7-16-20(19(15)14-4-2-1-3-5-14)21-24-18(27)12-17(26(21)25-16)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) NORWSQPVXYFCFO-UHFFFAOYSA-N 290334 9-Fluoro-10-phenyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 77::US10668071, Example 77 Plasminogen [101-181] Human 11.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290334&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528616 381610662 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910515 Fc1cccc(F)c1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H18F2N4O/c22-14-4-2-5-15(23)19(14)13-3-1-6-16-20(13)21-25-18(28)11-17(27(21)26-16)12-7-9-24-10-8-12/h1-6,11-12,24H,7-10H2,(H,25,28) DXKYIFAFNBESMY-UHFFFAOYSA-N 290335 10-(2,6-Difluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 78::US10668071, Example 78 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290335&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528617 381610663 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910516 Cc1cc(Cl)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17ClN4O/c1-9-6-11(17)15-12(7-9)20-21-13(8-14(22)19-16(15)21)10-2-4-18-5-3-10/h6-8,10,18H,2-5H2,1H3,(H,19,22) OOCUXPKWDWOLFE-UHFFFAOYSA-N 290336 10-Chloro-8-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 79::US10668071, Example 79 Plasminogen [101-181] Human 11.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290336&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528618 381610664 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910517 FC(F)(F)Oc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H19F3N4O2/c23-22(24,25)31-18-7-2-1-4-14(18)15-5-3-6-16-20(15)21-27-19(30)12-17(29(21)28-16)13-8-10-26-11-9-13/h1-7,12-13,26H,8-11H2,(H,27,30) AEUWBYNIQAHUAQ-UHFFFAOYSA-N 290337 4-(Piperidin-4-yl)-10-[2-(trifluoromethoxy)phenyl]pyrimido[1,2-b]indazol-2(1H)-on hydrochloride::US10098883, Example 80::US10668071, Example 80 Plasminogen [101-181] Human 18.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290337&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528619 381610665 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910518 Fc1cc(Br)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H14BrFN4O/c16-10-5-9(17)6-11-14(10)15-19-13(22)7-12(21(15)20-11)8-1-3-18-4-2-8/h5-8,18H,1-4H2,(H,19,22) ZHLHZRYKLMKZDQ-UHFFFAOYSA-N 290338 10-Bromo-8-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 81::US10668071, Example 81 Plasminogen [101-181] Human 16.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290338&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528620 381610666 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910519 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccccn4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-18-12-17(13-7-10-21-11-8-13)25-20(23-18)19-14(4-3-6-16(19)24-25)15-5-1-2-9-22-15/h1-6,9,12-13,21H,7-8,10-11H2,(H,23,26) HWHUZTMZNGMYEC-UHFFFAOYSA-N 290339 4-(Piperidin-4-yl)-10-(pyridin-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 82::US10668071, Example 82 Plasminogen [101-181] Human 20.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290339&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528621 381610667 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910520 O=c1cc(C2CCNCC2)n2nc3cccc(-c4nccs4)c3c2[nH]1 InChI=1S/C18H17N5OS/c24-15-10-14(11-4-6-19-7-5-11)23-17(21-15)16-12(18-20-8-9-25-18)2-1-3-13(16)22-23/h1-3,8-11,19H,4-7H2,(H,21,24) YRHDRRIEMZBQLD-UHFFFAOYSA-N 290340 4-(Piperidin-4-yl)-10-(1,3-thiazol-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 83::US10668071, Example 83 Plasminogen [101-181] Human 41.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290340&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528622 381610668 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910521 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccsc4)c3c2[nH]1 InChI=1S/C19H18N4OS/c24-17-10-16(12-4-7-20-8-5-12)23-19(21-17)18-14(13-6-9-25-11-13)2-1-3-15(18)22-23/h1-3,6,9-12,20H,4-5,7-8H2,(H,21,24) RTGPFWOGKHQYMX-UHFFFAOYSA-N 290341 4-(Piperidin-4-yl)-10-(3-thienyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 84::US10668071, Example 84 Plasminogen [101-181] Human 23.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290341&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528623 381610669 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910522 Cc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H22N4O/c1-14-5-2-3-6-16(14)17-7-4-8-18-21(17)22-24-20(27)13-19(26(22)25-18)15-9-11-23-12-10-15/h2-8,13,15,23H,9-12H2,1H3,(H,24,27) MEBQJFIUKMZVGA-UHFFFAOYSA-N 290342 10-(2-Methylphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 85::US10668071, Example 85 Plasminogen [101-181] Human 18.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290342&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528624 381610670 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910523 Cn1nccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H20N6O/c1-24-15(7-10-21-24)13-3-2-4-14-18(13)19-22-17(26)11-16(25(19)23-14)12-5-8-20-9-6-12/h2-4,7,10-12,20H,5-6,8-9H2,1H3,(H,22,26) PLWXETXSOMLQGU-UHFFFAOYSA-N 290343 10-(1-Methyl-1H-pyrazol-5-yl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 86::US10668071, Example 86 Plasminogen [101-181] Human 15.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290343&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528625 381610671 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910524 Cn1cc(cn1)-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H20N6O/c1-24-11-13(10-21-24)14-3-2-4-15-18(14)19-22-17(26)9-16(25(19)23-15)12-5-7-20-8-6-12/h2-4,9-12,20H,5-8H2,1H3,(H,22,26) UJPCPYLBWIQEJE-UHFFFAOYSA-N 290344 10-(1-Methyl-1H-pyrazol-4-yl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 87::US10668071, Example 87 Plasminogen [101-181] Human 25.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290344&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528626 381610672 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910525 O=c1cc(C2CCNCC2)n2nc3cccc(-c4cccs4)c3c2[nH]1 InChI=1S/C19H18N4OS/c24-17-11-15(12-6-8-20-9-7-12)23-19(21-17)18-13(16-5-2-10-25-16)3-1-4-14(18)22-23/h1-5,10-12,20H,6-9H2,(H,21,24) UHLPRPUEGYIKTH-UHFFFAOYSA-N 290345 4-(Piperidin-4-yl)-10-(2-thienyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 88::US10668071, Example 88 Plasminogen [101-181] Human 26.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290345&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528627 381610673 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910526 Cc1cc(Br)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17BrN4O/c1-9-6-11(17)15-12(7-9)20-21-13(8-14(22)19-16(15)21)10-2-4-18-5-3-10/h6-8,10,18H,2-5H2,1H3,(H,19,22) QBADPMPDDSTWJX-UHFFFAOYSA-N 290346 10-Bromo-8-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 89::US10668071, Example 89 Plasminogen [101-181] Human 36.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290346&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528628 381610674 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910527 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1Cl)C1CCNCC1 InChI=1S/C15H14ClFN4O/c16-14-9(17)1-2-10-13(14)15-19-12(22)7-11(21(15)20-10)8-3-5-18-6-4-8/h1-2,7-8,18H,3-6H2,(H,19,22) IDSVUURBHNHJFJ-UHFFFAOYSA-N 290347 10-Chloro-9-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 90::US10668071, Example 90 Plasminogen [101-181] Human 24.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290347&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528629 381610675 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910528 O=c1cc(C2CCNCC2)n2nc3cccc(-n4cncn4)c3c2[nH]1 InChI=1S/C17H17N7O/c25-15-8-14(11-4-6-18-7-5-11)24-17(21-15)16-12(22-24)2-1-3-13(16)23-10-19-9-20-23/h1-3,8-11,18H,4-7H2,(H,21,25) UGSRPIQETZIOTL-UHFFFAOYSA-N 290348 4-(Piperidin-4-yl)-10-(1H-1,2,4-triazol-1-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 91::US10668071, Example 91 Plasminogen [101-181] Human 27.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290348&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528630 381610676 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910529 Fc1ccccc1-c1c(F)ccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H18F2N4O/c22-14-4-2-1-3-13(14)19-15(23)5-6-16-20(19)21-25-18(28)11-17(27(21)26-16)12-7-9-24-10-8-12/h1-6,11-12,24H,7-10H2,(H,25,28) DCXJGHUGMDPRPO-UHFFFAOYSA-N 290349 9-Fluoro-10-(2-fluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 92::US10668071, Example 92 Plasminogen [101-181] Human 27.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290349&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528631 381610677 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910530 CCOc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C23H24N4O2/c1-2-29-20-9-4-3-6-16(20)17-7-5-8-18-22(17)23-25-21(28)14-19(27(23)26-18)15-10-12-24-13-11-15/h3-9,14-15,24H,2,10-13H2,1H3,(H,25,28) QAZLKHYYYLSJRO-UHFFFAOYSA-N 290350 10-(2-Ethoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 93::US10668071, Example 93 Plasminogen [101-181] Human 28.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290350&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528632 381610678 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910531 CC(C)Oc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C24H26N4O2/c1-15(2)30-21-9-4-3-6-17(21)18-7-5-8-19-23(18)24-26-22(29)14-20(28(24)27-19)16-10-12-25-13-11-16/h3-9,14-16,25H,10-13H2,1-2H3,(H,26,29) TVVBPMOLYUMJHD-UHFFFAOYSA-N 290351 10-(2-Isopropoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 94::US10668071, Example 94 Plasminogen [101-181] Human 35.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290351&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528633 381610679 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910532 Fc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H19FN4O/c22-16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-24-19(27)12-18(26(21)25-17)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) VPTAHBAWJZYJEI-UHFFFAOYSA-N 290314 10-(2-Fluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 57::US10098883, Example 95::US10668071, Example 95 Plasminogen [101-181] Human 18.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290314&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528598 381610644 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910533 O=c1cc(C2CCNCC2)n2nc3cccc(-n4cccn4)c3c2[nH]1 InChI=1S/C18H18N6O/c25-16-11-15(12-5-8-19-9-6-12)24-18(21-16)17-13(22-24)3-1-4-14(17)23-10-2-7-20-23/h1-4,7,10-12,19H,5-6,8-9H2,(H,21,25) QUHLGWOYWGATFZ-UHFFFAOYSA-N 290353 4-(Piperidin-4-yl)-10-(1H-pyrazol-1-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 96::US10668071, Example 96 Plasminogen [101-181] Human 26.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290353&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528634 381610680 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910534 COc1cccc(F)c1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H21FN4O2/c1-29-18-7-3-5-15(23)20(18)14-4-2-6-16-21(14)22-25-19(28)12-17(27(22)26-16)13-8-10-24-11-9-13/h2-7,12-13,24H,8-11H2,1H3,(H,25,28) JQAUZOWOZDCFCX-UHFFFAOYSA-N 290354 10-(2-Fluoro-6-methoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 97::US10668071, Example 97 Plasminogen [101-181] Human 30.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290354&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528635 381610681 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910535 O=c1cc(C2CCNCC2)n2nc3cccc(-n4nccn4)c3c2[nH]1 InChI=1S/C17H17N7O/c25-15-10-14(11-4-6-18-7-5-11)23-17(21-15)16-12(22-23)2-1-3-13(16)24-19-8-9-20-24/h1-3,8-11,18H,4-7H2,(H,21,25) GPCIYULNMITCIW-UHFFFAOYSA-N 290355 4-(Piperidin-4-yl)-10-(2H-1,2,3-triazol-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 98::US10668071, Example 98 Plasminogen [101-181] Human 27.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290355&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528636 381610682 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910536 O=c1cc(C2CCNCC2)n2nc3cccc(-n4ccnn4)c3c2[nH]1 InChI=1S/C17H17N7O/c25-15-10-14(11-4-6-18-7-5-11)24-17(20-15)16-12(21-24)2-1-3-13(16)23-9-8-19-22-23/h1-3,8-11,18H,4-7H2,(H,20,25) YDNXTICCLATOHH-UHFFFAOYSA-N 290356 4-(Piperidin-4-yl)-10-(1H-1,2,3-triazol-1-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 99::US10668071, Example 99 Plasminogen [101-181] Human 29.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290356&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528637 381610683 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910537 Cc1ccc(Cl)c2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17ClN4O/c1-9-2-3-11(17)14-15(9)20-21-12(8-13(22)19-16(14)21)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) ITROYPPTIOVFTM-UHFFFAOYSA-N 290357 10-Chloro-7-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 100::US10668071, Example 100 Plasminogen [101-181] Human 30.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290357&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528638 381610684 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910538 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(Cl)cccc3nn12 290325 (−)-trans-10-Chloro-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 68::US10668071, Example 101 Plasminogen [101-181] Human 35.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290325&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528607 381610653 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910539 O=c1cc(C2CCNCC2)n2nc3cccc(-c4cnc[nH]4)c3c2[nH]1 InChI=1S/C18H18N6O/c25-16-8-15(11-4-6-19-7-5-11)24-18(22-16)17-12(14-9-20-10-21-14)2-1-3-13(17)23-24/h1-3,8-11,19H,4-7H2,(H,20,21)(H,22,25) VXCLPZVODVOKMF-UHFFFAOYSA-N 290359 10-(1H-imidazol-5-yl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 103::US10668071, Example 103 Plasminogen [101-181] Human 110 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290359&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528639 381610686 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910540 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccc[nH]4)c3c2[nH]1 InChI=1S/C19H19N5O/c25-17-11-16(12-6-9-20-10-7-12)24-19(22-17)18-13(14-5-2-8-21-14)3-1-4-15(18)23-24/h1-5,8,11-12,20-21H,6-7,9-10H2,(H,22,25) UAEFQLZDEJNRHU-UHFFFAOYSA-N 290360 4-(piperidin-4-yl)-10-(1H-pyrrol-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 104::US10668071, Example 104 Plasminogen [101-181] Human 35.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290360&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528640 381610687 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910541 Oc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H16N4O2/c20-12-3-1-2-10-14(12)15-17-13(21)8-11(19(15)18-10)9-4-6-16-7-5-9/h1-3,8-9,16,20H,4-7H2,(H,17,21) AFLUEAATNHVJTJ-UHFFFAOYSA-N 290361 10-hydroxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrobromide::US10098883, Example 105::US10668071, Example 105 Plasminogen [101-181] Human 74.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290361&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528641 381610688 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910542 OC(=O)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H16N4O3/c21-13-8-12(9-4-6-17-7-5-9)20-15(18-13)14-10(16(22)23)2-1-3-11(14)19-20/h1-3,8-9,17H,4-7H2,(H,18,21)(H,22,23) MGJWNNOTDHWJEC-UHFFFAOYSA-N 290362 2-oxo-4-(piperidin-4-yl)-1,2-dihydropyrimido[1,2-b]indazole-10-carboxylic acid hydrochloride::US10098883, Example 106::US10668071, Example 106 Plasminogen [101-181] Human 420 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290362&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528642 381610689 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910543 FC(F)(F)COc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C17H17F3N4O2/c18-17(19,20)9-26-13-3-1-2-11-15(13)16-22-14(25)8-12(24(16)23-11)10-4-6-21-7-5-10/h1-3,8,10,21H,4-7,9H2,(H,22,25) LTPLPFKZDXYQHW-UHFFFAOYSA-N 290363 4-(piperidin-4-yl)-10-(2,2,2-trifluoroethoxy)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 107::US10668071, Example 107 Plasminogen [101-181] Human 34.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290363&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528643 381610690 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 910544 Nc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H17N5O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7,16H2,(H,18,21) FBRYWEWOAUMULU-UHFFFAOYSA-N 290364 10-amino-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 108::US10668071, Example 108 Plasminogen [101-181] Human 35.0 US Patent 10.7270/Q2KP8554 aid1804439 US10668071 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 6/2/2020 2/15/2021 BAYER PHARMA AKTIENGESELLSCHAFT http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290364&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528644 381610691 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1HPJ,1HPK,1PKR,4CIK Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00